SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
OneMedNet Corp Class A Common Stock
ONMD
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$4.72 – $5.16
Volume3,899
Market cap$28M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$28.31M
Price / earnings
—
Price / book
-8.05×
Price / sales
19.44×
EV / sales
19.68×
EV / EBITDA
-2.84×
Profitability
Earnings per share
-$1.46
Return on assets
-623.61%
Return on equity
241.79%
Dividend yield
0%
Liquidity and leverage
Debt / equity
-0.2×
Current ratio
0.28×
Quick ratio
0.28×
Cash ratio
0.08×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$6.7M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for ONMD, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$292K
$96K
$891K
$177K
$155K
$137K
$26K
$142K
Cost of revenue
$857K
$476K
$726K
$399K
$396K
$361K
$52K
$226K
Gross profit
-$565K
-$380K
$165K
-$222K
-$241K
-$224K
-$26K
-$84K
Selling, general and administrative
$1.37M
$1.86M
$2.8M
$1.69M
$1.44M
$1.65M
$2.35M
$1.95M
Research and development
$324K
$311K
$443K
$323K
$382K
$348K
$340K
$298K
Total operating expenses
$1.7M
$2.17M
$3.25M
$2.01M
$1.82M
$2M
$2.69M
$2.25M
Operating income
-$2.26M
-$2.55M
-$3.08M
-$2.24M
-$2.06M
-$2.22M
-$2.72M
-$2.34M
Interest expense
-$9K
-$10K
-$8K
-$6K
-$22K
-$31K
-$27K
-$36K
Income before taxes
-$2.17M
-$2.45M
-$3.14M
-$741K
-$725K
-$1.9M
-$2.37M
-$2.06M
Income taxes
$0
$0
$1K
$0
$0
$0
$2K
$0
Net income
-$2.17M
-$2.45M
-$3.14M
-$741K
$2.98M
-$1.9M
-$2.37M
-$2.06M
Net income attributable to common shareholders
-$2.17M
-$2.45M
-$3.14M
-$741K
$2.98M
-$1.9M
-$2.37M
-$2.06M
EBITDA
-$2.26M
-$2.54M
-$3.07M
-$2.23M
-$2.03M
-$2.21M
-$2.69M
-$2.33M
Basic earnings per share
-$0.40
-$0.40
-$0.57
-$0.10
$0.70
-$0.60
-$0.72
-$0.70
Diluted earnings per share
-$0.40
-$0.40
-$0.59
-$0.10
$0.70
-$0.60
-$0.72
-$0.70
Recent news
Company coverage with links to the original publishers.
OneMedNet (NASDAQ:ONMD) shares declined 11.51% in premarket trading on Tuesday, continuing weakness after a Friday rally. The company announced the commercial launch of its AI-powered real-world data (RWD) platform integrated with over 2,130 healthcare sites, converting customer evaluations into multi-year subscriptions to drive recurring revenue growth. The platform, powered by Palantir Technologies, aims to provide life sciences teams and researchers with near-real-time access to clinical data and faster cohort building.
OneMedNet Corporation announced that its regulatory-grade Real-World Data supported mlHealth 360 in obtaining FDA 510(k) clearance for Scaida BrainCT-ICH, an AI software solution that detects intracranial hemorrhage from head CT scans in approximately 5.97 seconds. The milestone demonstrates OneMedNet's value as a trusted data partner for regulated AI and life-sciences innovation.
OneMedNet Corporation, a leading curator of regulatory-grade Real World Data, has announced the appointment of Bob Golden as its new Chief Financial Officer. Mr. Golden is a Certified Public Accountant with over 40 years of experience and will be responsible for the company's financial and accounting operations.
Partner’s software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies Partner’s software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies
Secures new life science company customer through this globally recognized and trusted new channel Secures new life science company customer through this globally recognized and trusted new channel
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.